deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT07294898

A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Effect of a Low-Fat Meal and Evening Dosing on the Pharmacokinetics of KAI-7535 in Healthy Participants Living With Obesity or Overweight

Sponsor: Kailera

Conditions Obesity Overweight
Interventions KAI-7535
Updated 2 times since 2026 Last updated: Jan 28, 2026 Started: Dec 15, 2025 Primary completion: Jan 26, 2026 Completion: Jan 26, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07294898, this PHASE1 trial focuses on Obesity and Overweight and remains completed. Sponsored by Kailera, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE1

    Status: Not Yet Recruiting → Completed

  2. Jan 2026 — Feb 2026 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Dec 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kailera
Data source: Kailera

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations